Involvement of leukotriene B4 in murine dermatitis models.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical Pharmacology

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0006-2952(97)00464-4PMID 9484795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema

  2005cited by this paper
• The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.

  1995cited by this paper
• Clinical activity of leukotriene inhibitors.

  1995cited by this paper
• Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase.

  1994cited by this paper
• Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea‐pig skin

  1994cited by this paper
• Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene

  1994cited by this paper
• Altered inflammatory responses in leukotriene-deficient mice.

  1994cited by this paper
• Leukotriene B4 induces interleukin 5 generation from human T lymphocytes

  1993cited by this paper
• 5-Lipoxygenase activation in psoriasis: a dead issue?

  1993cited by this paper
• Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4hydrolase

  1992cited by this paper
• On the expression and regulation of 5-lipoxygenase in human lymphocytes.

  1992cited by this paper
• Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes.

  1992cited by this paper
• Leukotriene B4 transcriptionally activates interleukin‐6 expression involving NK‐xB and NF‐IL6

  1992cited by this paper
• Leukotriene B4 up-regulates IL-6 rather than IL-1 synthesis in human monocytes

  1991cited by this paper
• An Ultrastructural Study of the Response of Normal Skin to Epicutaneous Application of Leukotrience B4

  1991cited by this paper
• Leukotriene B4 in inflammation.

  1990cited by this paper
• Inflammation of guinea pig dermis

  1990cited by this paper
• Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

  1990cited by this paper
• Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.

  1989cited by this paper
• Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes.

  1989cited by this paper
• Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents

  1989cited by this paper
• Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulation.

  1989cited by this paper
• Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid

  1987cited by this paper
• Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2.

  1987cited by this paper
• Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)- and (12S)-hydroxyeicosatetraenoic acid.

  1987cited by this paper
• Leukotriene A4 hydrolase in the human lung. Inactivation of the enzyme with leukotriene A4 isomers.

  1987cited by this paper
• Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions.

  1986cited by this paper
• The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation

  1986cited by this paper
• Leukotriene B4 and 20-OH-LTB4 in purulent peritoneal exudates demonstrated by GC-MS.

  1986cited by this paper
• Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells.

  1984cited by this paper
• Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

  1984cited by this paper
• The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.

  1984cited by this paper
• The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

  1984cited by this paper
• Production of intraepidermal microabscesses by topical application of leukotriene B4.

  1984cited by this paper
• Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin

  1983cited by this paper
• Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.

  1983cited by this paper
• The release of leukotriene B4 during experimental inflammation.

  1983cited by this paper
• Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.

  1983cited by this paper
• Human alveolar macrophages produce leukotriene B4.

  1982cited by this paper
• Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils.

  1982cited by this paper
• THE INFLAMMATORY EFFECTS OF HYDROPEROXY AND HYDROXY ACID PRODUCTS OF ARACHIDONATE LIPOXYGENASE IN RABBIT SKIN

  1981cited by this paper
• Control of vascular permeability by polymorphonuclear leukocytes in inflammation

  1981cited by this paper
• The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4

  1981cited by this paper
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

  1980cited by this paper
• CALCIUM IONOPHORE A23187 INDUCES RELEASE OF CHEMOKINETIC AND AGGREGATING FACTORS FROM POLYMORPHO‐NUCLEAR LEUCOCYTES

  1980cited by this paper
• Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.

  1979cited by this paper

• Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors.

  2025cites this paper
• Polyunsaturated Fatty Acid-Derived Lipid Mediators That Regulate Epithelial Homeostasis.

  2022cites this paper
• Biosynthesis of leukotriene B4.

  2017cites this paper
• The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling

  2015cites this paper
• The role of leukotrienes in immunopathogenesis of rheumatoid arthritis

  2014cites this paper
• Targeting leukotriene B4 in inflammation

  2014cites this paper
• Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors

  2013cites this paper
• The role of leukotrienes in immunopathogenesis of rheumatoid arthritis

  2013cites this paper
• Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

  2011cites this paper
• Role of leukotriene B4 in 5-lipoxygenase metabolite- and allergy-induced itch-associated responses in mice.

  2010cites this paper
• Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.

  2009cites this paper
• Decreased activity of neutrophil glutathione peroxidase in chronic plaque-type psoriasis.

  2007cites this paper
• Molecular Events on Experimental Skin Inflammation and Modulation by Topical Anti-inflammatory Flavonoids

  2007cites this paper
• Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors.

  2006cites this paper
• Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.

  2006cites this paper
• In vitro pharmacological properties and composition of leaf essential oils and extracts of selected indigenous pelargonium (geraniaceae) species

  2006cites this paper
• Epoxide hydrolases: their roles and interactions with lipid metabolism.

  2005cites this paper
• Leukotriene A4 hydrolase as a target for cancer prevention and therapy.

  2004cites this paper
• Essential Fatty Acids and the Brain

  2003cites this paper
• THE MOUSE EAR AS A MODEL FOR CUTANEOUS IRRITATION

  2002cites this paper
• Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease.

  2002cites this paper
• A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase.

  2002cites this paper
• Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.

  2001cites this paper
• Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.

  2000cites this paper
• Essential fatty acids and the brain: possible health implications

  2000cites this paper
• Targeted Disruption of the Leukotriene B4Receptor in Mice Reveals Its Role in Inflammation and Platelet-Activating Factor–Induced Anaphylaxis

  2000cites this paper
• Modele animal du psoriasis destine a la prevention et au traitement du psoriasis humain

  1999cites this paper
• Phycocyanin Extract Reduces Leukotriene B4 Levels in Arachidonic Acid‐induced Mouse‐ear Inflammation Test

  1999cites this paper
• Effects of SA6541, a leukotriene A4 hydrolase inhibitor, and indomethacin on carrageenan-induced murine dermatitis.

  1998cites this paper
• Involvement of leukotriene B4 in arthritis models.

  1998cites this paper